Trial intelligence / Profile preview

Avapritinib in Advanced Systemic Mastocytosis (Phase 2, Open-label, Single Arm)

2017-004836-13Phase 2Completed

Sponsor

Blueprint Medicines

Start

Aug 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1